Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING

Prospective Analysis of Spinal Epidural Abscess

NCT05464251 · View on ClinicalTrials.gov ↗

Study Summary

This is a prospective study involving all patients treated at the University of Kentucky for spinal epidural abscess over a 2-year period. Based on ongoing referrals of patients with SEA, we expect that 200 patients will be enrolled during this time window. We propose to study all available clinical, pathological, radiological, and socioeconomic data of patients diagnosed with a spinal infection with or without a history of drug abuse over this study period. All patients' charts will be prospectively reviewed starting at the time of presentation for a period of 1 year.

Conditions Studied

Interventions

  • OTHER Prospective chart review of subjects diagnosed with spinal epidural abscess

Study Locations (1)

Kentucky

  • University of Kentucky — Lexington

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2022-07-12
Est. Completion 2027-06

Sponsor

Francis Farhadi

7 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05464251

The ClinicalTrials.gov registry entry for NCT05464251 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Francis Farhadi, which has 7 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 1 condition, with Spinal Epidural Abscess appearing as the primary indexed condition, and to 1 intervention — of which Prospective chart review of subjects diagnosed with spinal epidural abscess is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT05464251 reports 1 study location spanning 1 distinct geographic area — top geographies include Kentucky. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT05464251 about?

NCT05464251 is a clinical study titled "Prospective Analysis of Spinal Epidural Abscess". This is a prospective study involving all patients treated at the University of Kentucky for spinal epidural abscess over a 2-year period. Based on ongoing referrals of patients with SEA, we expect that 200 patients will be enrolled during this time window. We propose to study all available clinical...

What is the current status of trial NCT05464251?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2022-07-12. Estimated completion is 2027-06.

What conditions does trial NCT05464251 study?

This clinical trial studies the following conditions: Spinal Epidural Abscess. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT05464251?

The interventions under investigation include: Prospective chart review of subjects diagnosed with spinal epidural abscess (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT05464251?

This trial is sponsored by Francis Farhadi, which has 7 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT05464251 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial